Anaplastic lymphoma kinase positive histiocytosis presenting as hemocytopenia in an infant
- 2 October 2022
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (3) , e30010
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionBlood, 2022
- ALK-positive histiocytosis with disseminated disease responded to alectinib: a case reportAnnals of Palliative Medicine, 2021
- Notable therapeutic response in a patient with systemic juvenile xanthogranuloma with KIF5B‐ALK fusionPediatric Blood & Cancer, 2021
- Disseminated ALK-positive histiocytosis with KIF5B-ALK fusion in an adultLeukemia & Lymphoma, 2020
- ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinibVirchows Archiv, 2020
- ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusionLaboratory Investigation, 2019
- Activating Mutations in CSF1R and Additional Receptor Tyrosine Kinases in Sporadic and Familial Histiocytic NeoplasmsBlood, 2018
- Expanding the Phenotype of ALK-positive Histiocytosis: A Report of 2 CasesPediatric and Developmental Pathology, 2017
- ALKFusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted TherapyThe Oncologist, 2017
- ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancyBlood, 2008